Larry Biegelsen
Stock Analyst at Wells Fargo
(3.65)
# 786
Out of 4,944 analysts
328
Total ratings
50.64%
Success rate
5.43%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $11.13 | +16.80% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $77.68 | +13.29% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $86.48 | +7.54% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $87.36 | +15.61% | 13 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Overweight | $435 → $445 | $378.95 | +17.43% | 16 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $137 → $131 | $122.92 | +6.57% | 6 | Aug 1, 2025 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $6 → $3 | $1.54 | +94.81% | 7 | Aug 1, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $33 → $24 | $24.11 | -0.46% | 17 | Aug 1, 2025 | |
| GKOS Glaukos | Maintains: Equal-Weight | $86 → $92 | $91.79 | +0.23% | 15 | Jul 31, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $15 | $14.17 | +5.86% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $86.15 | +16.08% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $257.38 | +12.67% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $11.62 | +24.78% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $124 | $102.50 | +20.98% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $559 → $599 | $482.35 | +24.18% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $15.89 | +69.92% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $8.31 | +8.30% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $93 | $74.27 | +25.22% | 17 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1.29 → $0.68 | $1.27 | -46.46% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $103.22 | -5.06% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $75.33 | +18.15% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $9.32 | +82.40% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $174.42 | -12.85% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $79.96 | +17.56% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $92.91 | +5.48% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $14.12 | +247.03% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $129.40 | +5.10% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $62.79 | +11.48% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $195.96 | +37.78% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $53.79 | - | 2 | Nov 2, 2017 |
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $11.13
Upside: +16.80%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $77.68
Upside: +13.29%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $86.48
Upside: +7.54%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $87.36
Upside: +15.61%
Stryker
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $378.95
Upside: +17.43%
Teleflex
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $122.92
Upside: +6.57%
Pulmonx
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.54
Upside: +94.81%
Baxter International
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $24.11
Upside: -0.46%
Glaukos
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $91.79
Upside: +0.23%
Bausch + Lomb
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $14.17
Upside: +5.86%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $86.15
Upside: +16.08%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $257.38
Upside: +12.67%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $11.62
Upside: +24.78%
Jul 24, 2025
Maintains: Overweight
Price Target: $118 → $124
Current: $102.50
Upside: +20.98%
Jul 23, 2025
Maintains: Overweight
Price Target: $559 → $599
Current: $482.35
Upside: +24.18%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $15.89
Upside: +69.92%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $8.31
Upside: +8.30%
May 30, 2025
Maintains: Overweight
Price Target: $118 → $93
Current: $74.27
Upside: +25.22%
May 14, 2025
Maintains: Equal-Weight
Price Target: $1.29 → $0.68
Current: $1.27
Upside: -46.46%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $103.22
Upside: -5.06%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $75.33
Upside: +18.15%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $9.32
Upside: +82.40%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $174.42
Upside: -12.85%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $79.96
Upside: +17.56%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $92.91
Upside: +5.48%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $14.12
Upside: +247.03%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $129.40
Upside: +5.10%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $62.79
Upside: +11.48%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $195.96
Upside: +37.78%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $53.79
Upside: -